Research Project Grants (RPGs)
In fiscal year 2023, 1,369 competing RPGs were funded. Over 69.1% of competing dollars supported grants awarded within the established payline and requests for applications (RFAs) and the remainder supported grants as an exception to the fundable range. RFA funds accounted for 10.3% of the fiscal year 2023 competing dollars.
Number of RPG Awards
Includes Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards. Fiscal years 2020-2023 includes Cancer Moonshot funding.
RPGs Summary, Fiscal Years 2022-2023
| RPG Awards Funded | 2022 No. or % | 2022 Amount | 2023 No. or % | 2023 Amount |
|---|---|---|---|---|
| Total Funding for RPGs | 5,497 | $2,966,486 | 5,736 | $3,145,237 |
| SBIR/STTR | 207 | $151,396 | 228 | $175,373 |
| Funding for RPGs without SBIR/STTR Program | 5,290 | $2,815,090 | 5,508 | $2,969,864 |
| Continuation or Noncompeting Grants Funded | 3,933 | $2,013,233 | 4,139 | $2,125,093 |
| Competing Grants Funded | 1,357 | $665,061 | 1,369 | $697,786 |
| Administrative Supplements | 325 | $34,325 | 354 | $39,659 |
| Partial Assessment for DHHS Program Evaluation | $102,471 | $107,326 |
| Grant Category | R01 or Share | 2022 No. or % | 2022 Amount | 2023 No. or % | 2023 Amount |
|---|---|---|---|---|---|
| Grants within Paylines | 992 | $430,938 | 1,018 | $481,920 | |
| Traditional R01 | 710 | $371,261 | 776 | $428,468 | |
| RFA Grants | 139 | $82,897 | 115 | $71,919 | |
| Share of Competing Grant Funds | 12.5% | 10.3% | |||
| Exception Grants | 365 | $234,123 | 351 | $215,866 | |
| Share of Competing Grant Funds | 35.2% | 30.9% |
| Statistical Measure | 2022 | 2023 |
|---|---|---|
| Total Competing Application Requests (Excludes SBIR/STTR) | 8,932 | 8,618 |
| Funding Success Rate | 15% | 16% |
| Percentile Funding for R01 Grants | 16th | 17th |
| Average Cost-Competing | $490 | $510 |
| Average Reduction from Recommended/Requested Levels | -14% | -14% |
| Includes fiscal year 2023 Cancer Moonshot funding. Includes fiscal years 2022 through 2017 Moonshot carryover obligations. | ||
| Traditional R01 line (includes Trad R01 and converted R37) | ||
RPGs Funding Mechanisms
The "Other" category includes DP1, DP2, DP5, R00, R37, U01, U19,UH2, UH3, UG3, UA5, R50, UM1, R15, R55, R56 and R61 activities.
| RPG Mechanism | 2022 | 2023 | Description |
|---|---|---|---|
| R01 Traditional Grants | 11th & 16th | 12th & 17th | Percentile |
| P01 Program Projects | 17% Reduction | 17% Reduction | SPL Selected* |
| R03 Small Grants | 25 | 25 | Impact Score |
| R15 Academic Research | 25 | 25 | Impact Score |
| R21 Exploratory Phase I | 9th | 9th | Percentile |
| R33 Exploratory Phase II | N/A | N/A | SPL Selected* |
| R41/R42 STTR | 24 | 26 | Impact Score |
| R43/R44 SBIR | 24 | 27 | Impact Score |
| *SPL = Scientific Program Leaders (NCI) | |||
RPGs Requested and Awarded
The following table displays requested and awarded RPGs and the success rate for fiscal years 2022 and 2023. These numbers include Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards. The Download the Data link contains data for the prior ten years.
| Fiscal Year | Type | Number Requested | Amount Requested | Number Awarded | Amount Awarded | Success Rate |
|---|---|---|---|---|---|---|
| 2022 | Competing New | 9,580 | $4,902,539 | 1,324 | $635,623 | 14.8% |
| Competing Renewal | 431 | $335,464 | 154 | $107,730 | ||
| Competing Supplement | 28 | $8,867 | 12 | $3,363 | ||
| Competing Subtotal | 10,039 | $5,246,870 | 1,490 | $746,715 | ||
| Non- Competing | 4,007 | $2,219,770 | ||||
| FY 2022 RPG Total | 5,497 | $2,966,486 | ||||
| 2023 | Competing New | 9,302 | $4,888,297,784 | 1,319 | $653,918 | 15.4% |
| Competing Renewal | 427 | $341,237,643 | 179 | $130,281 | ||
| Competing Supplement | 0 | $0 | ||||
| Competing Subtotal | 9,729 | $5,229,535,427 | 1,498 | $784,199 | ||
| Non- Competing | 4,238 | $2,253,712 | ||||
| FY 2023 RPG Total | 5,736 | $3,037,911 | ||||
| Includes Small Business Innovation Research and Small Business Technology Transfer Awards. | ||||||
| Fiscal years 2023 through 2020 figures includes Cancer Moonshot funding data. | ||||||
| Success rate is the number of awarded grants divided by the number of awards requested. | ||||||
| Includes fiscal year 2023 Cancer Moonshot funding. Includes fiscal years 2022 through 2017 Moonshot carryover obligations. | ||||||
RPG Awards by Grant Activity Codes
This table displays awarded research project grants (RPG) data by grant activity code and count. Please visit NIH Activity Codes for more information on the descriptions.
| Year | Total No. Awarded | Total Amount | Average Cost |
|---|---|---|---|
| 2013 | 4,816 | $1,924,803 | $400 |
| 2014 | 4,814 | $1,939,623 | $403 |
| 2015 | 4,767 | $2,019,308 | $424 |
| 2016 | 4,666 | $2,068,869 | $443 |
| *2017 | 4,663 | $2,195,184 | $471 |
| *2018 | 4,780 | $2,366,530 | $495 |
| *2019 | 4,984 | $2,456,156 | $493 |
| *2020 | 5,070 | $2,677,206 | $528 |
| **2021 | 5,221 | $2,739,345 | $525 |
| *2022 | 5,497 | $2,864,015 | $521 |
| *2023 | 5,736 | $3,037,911 | $530 |
| *From fiscal year 2017 onward, RFAs will be accounted for in the actual grant mechanism categories under which they fall. | |||
| *Fiscal years 2023 through 2017 includes Cancer Moonshot funding appropriated that fiscal year and excludes all carryover obligations for fiscal years 2022 through 2018. | |||
| **Fiscal year 2021 includes multi-year funded grants with a 1 year average cost estimation. | |||
| Grant Code | 2022 Number | 2022 Amount | 2023 Number | 2023 Amount |
|---|---|---|---|---|
| R01 | 3,584 | $1,737,550 | 3,725 | $1,864,401 |
| DP1 | 0 | $0 | 0 | $0 |
| DP2 | 0 | $526 | 0 | $356 |
| DP5 | 0 | $0 | 0 | $0 |
| P01 | 99 | $200,007 | 96 | $197,631 |
| R00 | 93 | $22,788 | 104 | $25,555 |
| R37 | 277 | $128,583 | 343 | $164,733 |
| U01 | 325 | $239,325 | 321 | $236,674 |
| U19 | 7 | $12,400 | 7 | $12,552 |
| U34 | 1 | $284 | ||
| UH2 | 10 | $2,117 | 5 | $1,057 |
| R34 | 3 | $881 | ||
| R35 | 152 | $146,781 | 133 | $127,082 |
| R50 | 72 | $12,716 | 94 | $16,474 |
| UH3 | 26 | $16,703 | 30 | $24,463 |
| UA5 | 0 | $0 | 0 | $0 |
| UM1 | 14 | $52,568 | 21 | $53,731 |
| UG3 | 10 | $9,020 | 3 | $4,126 |
| R03 | 115 | $9,244 | 108 | $9,508 |
| R21 | 445 | $97,456 | 433 | $93,605 |
| R33 | 33 | $12,809 | 43 | $16,046 |
| R15 | 24 | $10,620 | 20 | $9,050 |
| R55 | 0 | $0 | 0 | $0 |
| R56 | 4 | $969 | 5 | $1,220 |
| R61 | 1 | $437 | 13 | $3,108 |
| RC2 | 0 | $0 | 0 | $0 |
| SBIR/STTR | 207 | $151,386 | 228 | $175,373 |
| Total | 5,497 | $2,864,015 | 5,736 | $3,037,911 |
| RPG Activity Codes with a "0" count displayed for No. are grants where NCI did not take the grant award count for the funding since NCI was not the Primary IC funding the award. | ||||
| *From fiscal year 2017 onward, RFAs will be accounted for in the actual grant mechanism categories under which they fall. | ||||
| *Fiscal years 2023 through 2017 includes Cancer Moonshot funding appropriated that fiscal year and excludes all carryover obligations for fiscal years 2022 through 2018. | ||||
| **Fiscal year 2021 includes multi-year funded grants with a 1 year average cost estimation. | ||||